Published in Eur Heart J on September 01, 1999
Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun (2003) 2.06
Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol (2008) 1.26
Thrombolytic therapy for central venous catheter occlusion. Haematologica (2011) 0.92
Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. J Thorac Dis (2015) 0.82
Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol (2004) 0.80
Streptokinase...never again. Eur Heart J (1999) 0.79
Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients. Clin Diagn Lab Immunol (2002) 0.77
Spontaneous psoas hematoma in a case of acute myocardial infarction following streptokinase infusion. Indian Heart J (2015) 0.75
Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1994) 8.63
Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet (1993) 5.48
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Retracted First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome. BMJ (1997) 4.24
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet (1992) 4.23
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1992) 3.40
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J (1985) 2.92
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A (2001) 2.71
Arterial versus capillary sampling for analysing blood gas pressures. BMJ (1995) 2.55
Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res (1990) 2.47
Superoxide dismutase in extracellular fluids. Clin Chim Acta (1982) 2.32
Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med (2003) 2.17
Cardiac troponin T. Lancet (1993) 2.13
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther (1999) 2.06
Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. J Pediatr (1991) 2.04
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther (2006) 2.00
Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J (2003) 1.95
Acute small-bowel obstruction following mesenteric perforation by CAPD catheter. Nephrol Dial Transplant (1997) 1.85
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscul Disord (1999) 1.83
The genetic determination of left ventricular mass in healthy adults. Eur Heart J (2003) 1.77
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
Pathogenicity of avian malaria in experimentally-infected Hawaii Amakihi. J Wildl Dis (2000) 1.75
Segregation and manifestations of the mtDNA tRNA(Lys) A-->G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet (1992) 1.73
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol (1996) 1.69
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol (1992) 1.65
A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation (1996) 1.64
Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun (1994) 1.63
EVerT: cryotherapy versus salicylic acid for the treatment of verrucae--a randomised controlled trial. Health Technol Assess (2011) 1.62
Physiological responses to mixing in large scale bioreactors. J Biotechnol (2001) 1.59
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res (1992) 1.56
The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol (2001) 1.53
Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency. J Pediatr (1993) 1.52
Post-marketing surveillance or drug acceptability study? Br J Clin Pharmacol (1987) 1.50
Contamination in trials of educational interventions. Health Technol Assess (2007) 1.50
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49
Parity and breast cancer: evidence of a dual effect. Br Med J (1980) 1.49
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet (1999) 1.48
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol (1991) 1.46
Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochim Biophys Acta (1994) 1.44
Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon. Postgrad Med J (1986) 1.43
QT dispersion and mortality after myocardial infarction. Lancet (1995) 1.42
Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth (1988) 1.41
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol (1996) 1.40
Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet (1992) 1.40
Half a loaf is better than waiting for the bread truck. A computerized mini-medical record for outpatient care. Arch Intern Med (1992) 1.39
Extracorporeal whole body hyperthermia treatment of HIV patients, a feasibility study. Int J Hyperthermia (1998) 1.38
A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection. Am J Gastroenterol (1993) 1.32
Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR. Nucleic Acids Res (2001) 1.30
The influence of antisense oligonucleotide length on dystrophin exon skipping. Mol Ther (2007) 1.30
Wildlife disease and conservation in Hawaii: pathogenicity of avian malaria (Plasmodium relictum) in experimentally infected iiwi (Vestiaria coccinea). Parasitology (1995) 1.28
A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. Br J Clin Pharmacol (1985) 1.27
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation (1993) 1.26
Histopathology of papilloma virus infection of the cervix uteri: the history, taxonomy, nomenclature and reporting of koilocytic dysplasias. J Clin Pathol (1983) 1.23
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit. Neuropharmacology (1996) 1.21
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochem Soc Trans (2007) 1.17
Translation of chick aortic elastin messenger ribonucleic acid. Comparison to elastin synthesis in chick aorta organ culture. Biochemistry (1980) 1.16
Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective. Br J Clin Pharmacol (1982) 1.16
Acute hydrocortisone myopathy. Br Med J (1980) 1.13
Tumour markers in breast cancer. Br J Cancer (1979) 1.13
A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J (1980) 1.11
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Eur Heart J (1985) 1.11
Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers. Eur J Clin Pharmacol (1979) 1.10
Circulatory effects of fast ventilator rates in preterm infants. Arch Dis Child (1990) 1.10
Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J (1975) 1.10
Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health (2004) 1.10
Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Am J Vet Res (1996) 1.09
Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1986) 1.09
Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland. Health Bull (Edinb) (1996) 1.09
Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol (1995) 1.08
Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J (1972) 1.08
Somatic colocalization of rat SK1 and D class (Ca(v)1.2) L-type calcium channels in rat CA1 hippocampal pyramidal neurons. J Neurosci (2001) 1.07
Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J (1980) 1.07
Strokes in the elderly - higher acute and 3-month mortality - an explanation. Cerebrovasc Dis (1999) 1.06
Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system. Br J Clin Pharmacol (1982) 1.06
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol (1992) 1.06
Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet (2000) 1.05
Familial abnormality of erythrocyte cation transport in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.05
Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul Disord (1997) 1.03
Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia. Lancet (1985) 1.03
Reproducibility and automatic measurement of QT dispersion. Eur Heart J (1996) 1.02
Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci (1992) 1.01
The effects of demographic shift on coronary heart disease mortality in a large migrant population at high risk. J Public Health Med (1991) 1.01
Prevention of immune precipitation by purified components of the alternative pathway. Clin Exp Immunol (1985) 1.00
Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol (1995) 1.00
The investigation of lactalbumin as a possible marker for human breast cancer. Eur J Cancer (1979) 0.99
ABC of sports medicine. Sudden death in sport. BMJ (1994) 0.99
Alcoholic ketoacidosis: a case report. Scott Med J (1987) 0.99
Mitochondrial DNA deletions in inclusion body myositis. Brain (1993) 0.99
(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent. Adv Exp Med Biol (1990) 0.98
Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab (1999) 0.98